Adalat LA 60mg Tablets incorrectly packaged in 30mg carton (CLDA (16)A/08)
Read the official alert on GOV.UK — MedRegWatch re-presents it; GOV.UK is the authoritative source.
| Type | Medicines recall/notification |
|---|---|
| Issued | 29 Sept 2016 |
| Product licences | PL 20774/1320 |
Product information
CLDA number
CLDA (16)A/08
MDR number
MDR 103-09/16
Company name
Product Licence Holder: Quadrant Pharmaceuticals Limited
Repackaged by: Pharmagen Limited
Product description
Adalat LA 60mg Tablets incorrectly packaged in 30mg carton
PL 20774/1320
Batch number/expiry
- Originator Batch Number: BXH84X5
- Parallel Import Batch Number: IB: C1604
- Expiry date: 08/2019
Brief description of the problem
There is a possibility that some packs of Parallel Imported Adalat LA 60mg Tablets batch BXH84X5 (originator name Adalat Oros 60mg) have been incorrectly repackaged into 30mg cartons.
Pharmacists are asked to check their stock of Adalat LA 30mg Tablets for any packs of batch BXH84X5.
Company contact
If a 30mg carton is found, please contact:
AAH Customer Services
Tel: 0844 561 8899
Hold any of these licences?Check all your PL numbers against the full archive in one paste — or join the waitlist for automatic matching and an inspection-ready recall register.